NN7999-3895: Safety and Efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophilia B

Disease Sites:

Hematologic

Staging:

Phase III

Age Group:

Children

Therapies:

Therapy (NOS)

Drugs:

N9-GP (nonacog beta pegol)

Principal Investigator(s):

Wheeler, Allison

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

12-15-2015

Trial Type:

Treatment

Protocol ID:

VICCNCBH1756

National Clinical Trial ID:

NCT02141074

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available